Minoru Kanaya

  • Post doc MD, PhD
 

Publications 2019

Senjo H, Kanaya M, Izumiyama K, Minauchi K, Hirata K, Mori A, Saito M, Tanaka M, Iijima H, Tsukamoto E, Itoh K, Ota S, Morioka M, Hashimoto D, Teshima T, North Japan Hematology Study Group (NJHSG) (2019)
Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on 18 F-FDG PET/CT in newly diagnosed patients with diffuse large B-cell lymphoma
Cancer Med, 8 (3), 953-962
DOI 10.1002/cam4.1973, PubMed 30790452

Publications 2018

Saito M, Miyashita K, Miura Y, Ogasawara R, Kanaya M, Izumiyama K, Mori A, Kondo T, Tanaka M, Morioka M, Tanaka S (2018)
Coexistence of primary colorectal follicular lymphoma and multiple myeloma: a case report
Int J Gen Med, 11, 363-367
DOI 10.2147/IJGM.S171387, PubMed 30254481

Saito M, Senjo H, Kanaya M, Izumiyama K, Mori A, Tanaka M, Morioka M, Ieko M (2018)
Acquired hemophilia A developing cerebral infarction 36 days after the frequent administration of bypass hemostatic agents
Hematol Rep, 10 (3), 7453
DOI 10.4081/hr.2018.7453, PubMed 30283617

Saito M, Senjo H, Kanaya M, Izumiyama K, Mori A, Tanaka M, Morioka M, Miyashita K, Ishida Y (2018)
Late duodenal metastasis from renal cell carcinoma with newly developed malignant lymphoma: A case report
Mol Clin Oncol, 8 (4), 553-556
DOI 10.3892/mco.2018.1563, PubMed 29556388

Senjo H, Mori A, Kanaya M, Izumiyama K, Okada K, Takeyabu K, Tobioka H, Saito M, Tanaka M, Teshima T, Morioka M (2018)
[Pyothorax-associated lymphoma with the expression of Epstein-Barr virus latent genes]
Nihon Ronen Igakkai Zasshi, 55 (1), 143-147
DOI 10.3143/geriatrics.55.143, PubMed 29503358

Publications 2017

Kanaya M, Endo T, Hashimoto D, Endo S, Takemura R, Okada K, Hatanaka KC, Matsuno Y, Teshima T (2017)
Diffuse large B-cell lymphoma with a bulky mass in the cranial vault
Int J Hematol, 106 (2), 147-148
DOI 10.1007/s12185-017-2229-x, PubMed 28390034

Kanaya M, Hayashi Y, Hashimoto D, Endo T, Sugita J, Ohigashi H, Hashiguchi J, Matsukawa T, Matsuoka S, Kosugi-Kanaya M, Goto H, Onozawa M, Kahata K, Fujimoto K, Kondo T, Akizawa K, Shibuya H, Shimizu C, Teshima T (2017)
MALDI-TOF MS in post-transplant bloodstream infections: reliable identification of causative bacteria in the neutropenic phase
Bone Marrow Transplant, 52 (5), 778-780
DOI 10.1038/bmt.2016.365, PubMed 28134922

Publications 2016

Kanaya M, Shibuya K, Hirochika R, Kanemoto M, Ohashi K, Okada M, Wagatsuma Y, Cho Y, Kojima H, Teshima T, Imamura M, Sakamaki H, Shibuya A (2016)
Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease
PLoS One, 11 (6), e0154173
DOI 10.1371/journal.pone.0154173, PubMed 27257974

Kasahara K, Onozawa M, Miyashita N, Yokohata E, Yoshida M, Kanaya M, Kosugi-Kanaya M, Takemura R, Takahashi S, Sugita J, Shigematsu A, Takahata M, Fujisawa S, Hashimoto D, Fujimoto K, Endo T, Kondo T, Teshima T (2016)
Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy
Case Rep Hematol, 2016, 2373902
DOI 10.1155/2016/2373902, PubMed 27034857

Saito M, Kanaya M, Izumiyama K, Mori A, Irie T, Tanaka M, Morioka M, Ieko M (2016)
Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases
Int J Gen Med, 9, 393-399
DOI 10.2147/IJGM.S118422, PubMed 27843336

Publications 2014

Nabekura T, Kanaya M, Shibuya A, Fu G, Gascoigne NR, Lanier LL (2014)
Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection
Immunity, 40 (2), 225-34
DOI 10.1016/j.immuni.2013.12.011, PubMed 24440149

Publications 2012

Kanaya M, Nabekura T, Shibuya K, Shibuya A (2012)
[Critical role of activating immune receptor DNAM-1 in the development of acute GVHD]
Rinsho Ketsueki, 53 (5), 497-503
PubMed 22728551

Page visits: 521